Independent review of new MS drugs

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Independent review of new MS drugs

Postby cheerleader » Thu Apr 23, 2015 8:00 am

Prescrire ("to prescribe" in French) is an international medical journal, which uses evidence based science to make recommendations on drugs. It is written by health care professionals for health care professionals, but it is unique in that it does not accept any pharmaceutical monies for advertising or for payment to reviewers. This journal makes money by having 33,500 subscribers---medical professionals who turn to this journal for unbiased information. This is a completely independent journal---they have signed a "Non, Merci" (no, thank you) charter to maintain no conflicts of interest.

Here is Prescrire's recent publications on Tysabri, Lemtrada and Aubagio from their March issue: ... -must.html

Husband dx RRMS 3/07
dx dual jugular vein stenosis (CCSVI) 4/09
User avatar
Family Elder
Posts: 5357
Joined: Mon Sep 10, 2007 2:00 pm
Location: southern California


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service